Advertisement
Advertisement
TMO
Thermo Fisher Scientific, Inc.
599.69
USDSponsored
+5.69
+0.96%
Aug 10, 16:00 UTC -4
Closed
Pre-Market
598.76
-0.93
-0.15%
TMO Earnings Reports
Positive Surprise Ratio
TMO beat 36 of 42 last estimates.
86%
Next Report
Date of Next Report
Oct 20, 2026
Estimate for Q3 26 (Revenue/ EPS)
$12.06B
/$6.47
Implied change from Q2 26 (Revenue/ EPS)
+0.57%
/+7.30%
Implied change from Q3 25 (Revenue/ EPS)
+8.45%
/+11.74%
Thermo Fisher Scientific, Inc. earnings per share and revenue
On Jul 23, 2026, TMO reported earnings of 6.03 USD per share (EPS) for Q2 26, beating the estimate of 5.76 USD, resulting in a 4.54% surprise. Revenue reached 11.99 billion, compared to an expected 11.82 billion, with a 1.49% difference. The market reacted with a +8.71% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 18 analysts forecast an EPS of 6.47 USD, with revenue projected to reach 12.06 billion USD, implying an increase of 7.30% EPS, and increase of 0.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
GLOBUS MEDICAL INC
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.12
Actual
$1.34
Surprise
+19.50%
Teleflex Incorporated
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.29
Actual
$1.76
Surprise
+36.04%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.36
Surprise
+1.96%
Artivion, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.01
Actual
-$0.28
Surprise
-2,845.10%
Tactile Systems Technology, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.14
Actual
$0.34
Surprise
+131.45%
Mesa Laboratories Inc
Report Date
Aug 10, 2026 For Q1 27
Estimate
$0.03
Actual
$2.61
Surprise
+8,429.41%
Delcath Systems Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.09
Actual
$0.07
Surprise
+176.25%
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
Inogen Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+10.88%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.27
Surprise
-8.78%
FAQ
What were Thermo Fisher Scientific, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Thermo Fisher Scientific, Inc. reported EPS of $6.03, beating estimates by 4.54%, and revenue of $11.99B, 1.49% above expectations.
How did the market react to Thermo Fisher Scientific, Inc.'s Q2 2026 earnings?
The stock price moved up 8.71%, changed from $526.46 before the earnings release to $572.32 the day after.
When is Thermo Fisher Scientific, Inc. expected to report next?
The next earning report is scheduled for Oct 20, 2026.
What are the forecasts for Thermo Fisher Scientific, Inc.'s next earnings report?
Based on 18
analysts, Thermo Fisher Scientific, Inc. is expected to report EPS of $6.47 and revenue of $12.06B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement